Skip to Content

Anti-PD-1 monoclonal antibodies

Other names: anti-programmed cell death-1 (PD-1) monoclonal antibodies, immune checkpoint inhibitors, programmed death-ligand 1 (PD-L1) blocking antibodies

What are Anti-PD-1 monoclonal antibodies?

Programmed cell death protein 1 (PD-1) is an inhibitory receptor that is expressed on some tumor cells and causes down regulation of the immune system by reducing T-cell activity. Anti-PD-1 monoclonal antibodies block the PD-1 receptor so the T cells are no longer inhibited and therefore activates the immune response against the tumor.

List of Anti-PD-1 monoclonal antibodies:

View by  Brand | Generic
Drug Name Reviews Avg. Ratings
Libtayo (Pro)
Generic name: cemiplimab
2 reviews
Opdivo (Pro)
Generic name: nivolumab
45 reviews
Keytruda (Pro)
Generic name: pembrolizumab
101 reviews
Bavencio (Pro)
Generic name: avelumab
0 reviewsAdd rating
Imfinzi (Pro)
Generic name: durvalumab
0 reviewsAdd rating
Tecentriq (Pro)
Generic name: atezolizumab
1 reviewAdd rating
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.